Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Odense University Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
The project will evaluate 1) the postprandial metabolism and 2) continuous glucose levels in subjects diagnosed with Idiopathic Ketotic Hypoglycemia (IKH)) and healthy control subjects.
IKH is a common, but not fully understood, condition in children, and in some the condition may persist in adulthood. In the present study we seek to evaluate the postprandial metabolism in adult subjects diagnosed with IKH through a clinical study including:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Subjects diagnosed with IKH | Experimental | 10 patients, diagnosed with IKH |
|
| Healthy control subjects | Experimental | 10 subjects, healthy, matched for gender, BMI, age |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Oral glucose tolerance test | Biological | Consumption of 75 grams of glucose, diluted in water, added 1,5 g of acetaminophen. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Plasma glucose | The intergroup difference in peak to nadir difference in plasma glucose following OGTT/MMT | -120, -60, -30, 0, 15, 30, 45, 60, 90, 120, 150, 180 minutes |
| Time in range (CGM) | The intergroup difference in time spend in glycemic range, measured by CGM | 0-14 days of CGM-period |
| Measure | Description | Time Frame |
|---|---|---|
| Endogenous glucose production | Rate of appearance of glucose, measured by tracer dilution technique | -120,, -60, -30, 0, 15, 30, 45, 60, 90, 120, 150, 180 minutes |
| Glucose revomal | Rate of disappearance of glucose, measured by tracer dilution technique |
Not provided
Inclusion Criteria:
Healthy control participants
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Center for Clinical Metabolic Research, Department of Medicine, Gentofte Hospital | Hellerup | Copenhagen | 2900 | Denmark |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007333 | Insulin Resistance |
| ID | Term |
|---|---|
| D006946 | Hyperinsulinism |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D005951 | Glucose Tolerance Test |
| C009907 | 2-methylcyclopentadienyl manganese tricarbonyl |
| ID | Term |
|---|---|
| D001774 | Blood Chemical Analysis |
| D019963 | Clinical Chemistry Tests |
| D019411 | Clinical Laboratory Techniques |
| D019937 | Diagnostic Techniques and Procedures |
Not provided
Not provided
A case-control intervention study.
Not provided
Not provided
Not provided
Not provided
|
| Mixed meal test | Biological | Consumption of a standardized liquid meal, with caloric and dietary content equal to a standard meal. |
|
|
| -120, -60, -30, 0, 15, 30, 45, 60, 90, 120, 150, 180 minutes |
| Amino acids | Plasma concentrations of amino acids | -120,-60, -30, 0, 15, 30, 45, 60, 90, 120, 150, 180 minutes |
| Insulin | Plasma concentrations of insulin | -120,-60, -30, 0, 15, 30, 45, 60, 90, 120, 150, 180 minutes |
| Glucagon | Plasma concentrations of glucagon | -120,-60, -30, 0, 15, 30, 45, 60, 90, 120, 150, 180 minutes |
| Glucagon like peptide-1 (GLP-1) | Plasma concentrations of GLP-1 | -120,-60, -30, 0, 15, 30, 45, 60, 90, 120, 150, 180 minutes |
| Glucose-dependent insulinotropic polypeptide (GIP) | Plasma concentrations of GIP | -120,-60, -30, 0, 15, 30, 45, 60, 90, 120, 150, 180 minutes |
| Coefficients of variation (CV) of plasma glucose | CV of plasma glucose measured by CGM | 0-14 days of CGM-period |
| Mean plasma glucose | Average value of plasma glucose measured by CGM | 0-14 days of CGM-period |
| Risk of hypoglycemia | Time spend in hypoglycemia measured by CGM | 0-14 days of CGM-period |
| D003933 | Diagnosis |
| D003940 | Diagnostic Techniques, Endocrine |
| D008919 | Investigative Techniques |